ArticleSurgical endoscopy2026
Diagnostic value of peroral choledochoscopy combined with modified biopsy forceps for malignant biliary strictures: a two-center retrospective study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
BACKGROUND AND
aimsPathological evaluation is crucial for diagnosing biliary strictures. This study aimed to evaluate the diagnostic efficacy and safety of peroral cholangioscopy combined with modified biopsy forceps for malignant biliary strictures.
methodsWe retrospectively collected data from inpatients with suspected extrahepatic malignant biliary strictures who underwent peroral cholangioscopy at Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, and The First Affiliated Hospital of Shihezi University from January 2020 to March 2025. The experimental group used peroral cholangioscopy combined with modified biopsy forceps, and the control group used peroral cholangioscopy. We compared the diagnostic efficacy and safety of the two biopsy methods.
resultsA total of 158 patients were included in the study, with 79 patients each in the experimental group and the control group. The detection rate of carcinoma in situ (high-grade intraepithelial neoplasia/severe dysplasia) was significantly higher in the experimental group than in the control group (32.9% vs 6.3%, P < 0.001). Regarding diagnostic efficacy and safety, the accuracy (93.7% vs 72.2%, P < 0.001), sensitivity (93.2% vs 71.4%, P < 0.001), negative predictive value (50.0% vs 8.3%, P = 0.014) and negative likelihood ratio (0.068 vs 0.286) of the experimental group were significantly superior to those of the control group. There was no significant difference between the two groups in terms of specificity (100.0% vs 100.0%, P = 1.000), positive predictive value (100.0% vs 100.0%, P = 1.000), or the incidence of adverse events (7.6% vs 8.9%, P = 1.000).
conclusionsCompared with POCS-guided biopsy using dedicated forceps, peroral cholangioscopy combined with modified biopsy forceps demonstrates higher diagnostic efficacy for malignant biliary strictures and maintains a good safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.